# Pennantpark Investment Corp: financial statements, quarterly

PNNT · NYSE · CIK 1383414 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/pnnt.md) · [Financials](/companies/pnnt/financials.md) · [Filings](/companies/pnnt/filings.md) · [Insiders](/companies/pnnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnnt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [12.3 d](/filings/0001193125-26-021227.md) | [10.7](/filings/0000950170-25-017048.md) | [16.1](/filings/0000950170-25-069165.md) | [3.7](/filings/0000950170-25-106538.md) | [18.4 d](/filings/0001193125-26-021227.md) | [16.1](/filings/0001193125-26-042780.md) | [9.5](/filings/0001193125-26-211879.md) | [8.2](/filings/0001193125-26-342350.md) | [(1.0) d](/filings/0001193125-26-021227.md) | [9.0](/filings/0001193125-26-042780.md) | [(2.3)](/filings/0001193125-26-211879.md) | [4.5](/filings/0001193125-26-342350.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.8](/filings/0000950170-24-130670.md) | [36.9](/filings/0000950170-24-012191.md) | [35.4](/filings/0000950170-24-055646.md) | [59.2](/filings/0000950170-24-092751.md) | [49.9](/filings/0001193125-26-021227.md) | [55.9](/filings/0000950170-25-017048.md) | [32.6](/filings/0000950170-25-069165.md) | [70.5](/filings/0000950170-25-106538.md) | [51.8](/filings/0001193125-26-021227.md) | [28.2](/filings/0001193125-26-042780.md) | [29.7](/filings/0001193125-26-211879.md) | [27.7](/filings/0001193125-26-342350.md) |
| Total assets | $m | [1,157](/filings/0000950170-24-130670.md) | [1,267](/filings/0000950170-24-012191.md) | [1,291](/filings/0000950170-24-055646.md) | [1,333](/filings/0000950170-24-092751.md) | [1,389](/filings/0001193125-26-021227.md) | [1,412](/filings/0000950170-25-017048.md) | [1,258](/filings/0000950170-25-069165.md) | [1,253](/filings/0000950170-25-106538.md) | [1,350](/filings/0001193125-26-342350.md) | [1,294](/filings/0001193125-26-042780.md) | [1,258](/filings/0001193125-26-211879.md) | [1,263](/filings/0001193125-26-342350.md) |
| Total liabilities | $m | [655](/filings/0000950170-24-130670.md) | [768](/filings/0000950170-24-012191.md) | [790](/filings/0000950170-24-055646.md) | [841](/filings/0000950170-24-092751.md) | [895](/filings/0001193125-26-021227.md) | [918](/filings/0000950170-25-017048.md) | [770](/filings/0000950170-25-069165.md) | [772](/filings/0000950170-25-106538.md) | [886](/filings/0001193125-26-342350.md) | [836](/filings/0001193125-26-042780.md) | [819](/filings/0001193125-26-211879.md) | [835](/filings/0001193125-26-342350.md) |
| Shareholders' equity | $m | [502](/filings/0000950170-25-106538.md) | [499](/filings/0000950170-24-012191.md) | [502](/filings/0000950170-25-106538.md) | [491](/filings/0000950170-25-106538.md) | [494](/filings/0001193125-26-342350.md) | [494](/filings/0001193125-26-211879.md) | [488](/filings/0001193125-26-342350.md) | [481](/filings/0001193125-26-342350.md) | [464](/filings/0001193125-26-342350.md) | [457](/filings/0001193125-26-211879.md) | [439](/filings/0001193125-26-342350.md) | [428](/filings/0001193125-26-342350.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0001193125-26-021227.md) | [(155)](/filings/0000950170-25-017048.md) | [4.3 d](/filings/0000950170-25-069165.md) | [(16.9) d](/filings/0000950170-25-106538.md) | [(4.7) d](/filings/0001193125-26-021227.md) | [18.7](/filings/0001193125-26-042780.md) | [142 d](/filings/0001193125-26-211879.md) | [51.5 d](/filings/0001193125-26-342350.md) | [(108) d](/filings/0001193125-26-021227.md) | [135](/filings/0001193125-26-042780.md) | [36.4 d](/filings/0001193125-26-211879.md) | [50.1 d](/filings/0001193125-26-342350.md) |
| Dividends paid | $m | [13.0 d](/filings/0001193125-26-021227.md) | [22.8](/filings/0000950170-25-017048.md) | [13.7 d](/filings/0000950170-25-069165.md) | [13.7 d](/filings/0000950170-25-106538.md) | [15.7 d](/filings/0001193125-26-021227.md) | [15.7](/filings/0001193125-26-042780.md) | [15.7 d](/filings/0001193125-26-211879.md) | [15.7 d](/filings/0001193125-26-342350.md) | [20.9 d](/filings/0001193125-26-021227.md) | [10.4](/filings/0001193125-26-042780.md) | [15.7 d](/filings/0001193125-26-211879.md) | [15.7 d](/filings/0001193125-26-342350.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.2](/filings/0000950170-25-106538.md) | [65.3](/filings/0001193125-26-042780.md) | [65.3](/filings/0001193125-26-211879.md) | [65.3](/filings/0001193125-26-342350.md) | [65.3](/filings/0001193125-26-042780.md) | [65.3](/filings/0001193125-26-211879.md) | [65.3](/filings/0001193125-26-342350.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,296,094 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342350.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.